Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP854327.RAhH9rOw07FrLvGcivzSswri7dYy3Bz9YEYJQX6ktlmcg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP854327.RAhH9rOw07FrLvGcivzSswri7dYy3Bz9YEYJQX6ktlmcg130_assertion type Assertion NP854327.RAhH9rOw07FrLvGcivzSswri7dYy3Bz9YEYJQX6ktlmcg130_head.
- NP854327.RAhH9rOw07FrLvGcivzSswri7dYy3Bz9YEYJQX6ktlmcg130_assertion description "[Our results indicate that AD-PTEN sensitization of breast cancer to LY294002 is achieved by increased GSK-3? activity, thus resulting in inhibition of the ?-catenin signaling pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP854327.RAhH9rOw07FrLvGcivzSswri7dYy3Bz9YEYJQX6ktlmcg130_provenance.
- NP854327.RAhH9rOw07FrLvGcivzSswri7dYy3Bz9YEYJQX6ktlmcg130_assertion evidence source_evidence_literature NP854327.RAhH9rOw07FrLvGcivzSswri7dYy3Bz9YEYJQX6ktlmcg130_provenance.
- NP854327.RAhH9rOw07FrLvGcivzSswri7dYy3Bz9YEYJQX6ktlmcg130_assertion SIO_000772 22710837 NP854327.RAhH9rOw07FrLvGcivzSswri7dYy3Bz9YEYJQX6ktlmcg130_provenance.
- NP854327.RAhH9rOw07FrLvGcivzSswri7dYy3Bz9YEYJQX6ktlmcg130_assertion wasDerivedFrom befree-20140225 NP854327.RAhH9rOw07FrLvGcivzSswri7dYy3Bz9YEYJQX6ktlmcg130_provenance.
- NP854327.RAhH9rOw07FrLvGcivzSswri7dYy3Bz9YEYJQX6ktlmcg130_assertion wasGeneratedBy ECO_0000203 NP854327.RAhH9rOw07FrLvGcivzSswri7dYy3Bz9YEYJQX6ktlmcg130_provenance.